Qube Research & Technologies (QRT)
CLDI icon

Qube Research & Technologies (QRT)’s Calidi Biotherapeutics CLDI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$338 – 3903
2024
Q1 		– Sell
-1
Closed -$1.63K – 4112
2023
Q4 		$4.16K Buy
+1
New +$4.29K ﹤0.01% 3742

Other funds holding CLDI

RWI
Red Wave Investments Dillsburg, Pennsylvania $394M AUM 20.27% 1-Year Est. Return
CI
CPR Investments Rochester, Michigan $130M AUM 29.56% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $533M AUM 20.75% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $608M AUM 25.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLDI Position: Q2 2024 in Review

Qube Research & Technologies (QRT) held its Calidi Biotherapeutics (CLDI) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3903.

Qube Research & Technologies (QRT) first reported a position in CLDI in Q4 2023 and has held it in 1 quarter since. The position peaked at $4.16K in Q4 2023. 29 funds tracked by Wall St. Rank hold CLDI as of Q2 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Calidi Biotherapeutics worth $0 as of Q2 2024.
  • Qube Research & Technologies (QRT) left its Calidi Biotherapeutics share count unchanged in Q2 2024.
  • Calidi Biotherapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2024, its #3903 holding.
  • Qube Research & Technologies (QRT) first reported a position in Calidi Biotherapeutics in Q4 2023 and has held it in 1 quarter since.
  • Qube Research & Technologies (QRT)'s Calidi Biotherapeutics position peaked at $4.16K in Q4 2023.
  • 29 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.